Publication Information

{'id': 'https://openalex.org/W2353293259', 'doi': None, 'title': 'Analysis of 1933 ADR reports in PLA General Hospital', 'display_name': 'Analysis of 1933 ADR reports in PLA General Hospital', 'publication_year': 2008, 'publication_date': '2008-01-01', 'ids': {'openalex': 'https://openalex.org/W2353293259', 'mag': '2353293259'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-YWYY200801005.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764537526', 'display_name': 'Chinese Journal of Drug Application and Monitoring', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5081766211', 'display_name': 'Guiyang Liu', 'orcid': 'https://orcid.org/0009-0000-3383-9409'}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Liu Gui-yang', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5081766211'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 63}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T13970', 'display_name': 'Pharmacy and Medical Practices', 'score': 0.9955, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T13970', 'display_name': 'Pharmacy and Medical Practices', 'score': 0.9955, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11943', 'display_name': 'Pharmacovigilance and Adverse Drug Reactions', 'score': 0.9866, 'subfield': {'id': 'https://openalex.org/subfields/3005', 'display_name': 'Toxicology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12547', 'display_name': 'Pharmaceutical studies and practices', 'score': 0.955, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/drug-reaction', 'display_name': 'Drug reaction', 'score': 0.5773527}, {'id': 'https://openalex.org/keywords/adverse-drug-reaction', 'display_name': 'Adverse drug reaction', 'score': 0.53838766}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.95168924}, {'id': 'https://openalex.org/C57658597', 'wikidata': 'https://www.wikidata.org/wiki/Q1550789', 'display_name': 'Pharmacovigilance', 'level': 3, 'score': 0.7873033}, {'id': 'https://openalex.org/C2993432071', 'wikidata': 'https://www.wikidata.org/wiki/Q45959', 'display_name': 'Drug reaction', 'level': 3, 'score': 0.5773527}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.57153356}, {'id': 'https://openalex.org/C2780542314', 'wikidata': 'https://www.wikidata.org/wiki/Q45959', 'display_name': 'Adverse drug reaction', 'level': 3, 'score': 0.53838766}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.44319302}, {'id': 'https://openalex.org/C177713679', 'wikidata': 'https://www.wikidata.org/wiki/Q679690', 'display_name': 'Intensive care medicine', 'level': 1, 'score': 0.35211998}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-YWYY200801005.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764537526', 'display_name': 'Chinese Journal of Drug Application and Monitoring', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.87, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2388977500', 'https://openalex.org/W2385786616', 'https://openalex.org/W2379467729', 'https://openalex.org/W2377382311', 'https://openalex.org/W2376785888', 'https://openalex.org/W2376221534', 'https://openalex.org/W2374758319', 'https://openalex.org/W2374732591', 'https://openalex.org/W2372636944', 'https://openalex.org/W2369772308', 'https://openalex.org/W2367104923', 'https://openalex.org/W2365105474', 'https://openalex.org/W2359532112', 'https://openalex.org/W2356924463', 'https://openalex.org/W2354485727', 'https://openalex.org/W2353980077', 'https://openalex.org/W2353966117', 'https://openalex.org/W2349161128', 'https://openalex.org/W2347473752', 'https://openalex.org/W2347431284'], 'abstract_inverted_index': {'Objective:To': [0], 'investigate': [1], 'the': [2, 23, 52, 92, 118, 132], 'essential': [3, 129], 'features': [4], 'of': [5, 17, 26, 41, 51, 75, 95, 103, 121, 150], 'adverse': [6], 'drug': [7, 19, 125, 151], 'reaction(ADR)': [8], 'which': [9], 'take': [10], 'place': [11], 'in': [12, 30, 107], 'our': [13], 'hospital,': [14], 'avoid': [15], 'risk': [16], 'clinical': [18], 'use,': [20], 'and': [21, 57, 63, 68, 99, 110, 134], 'control': [22], 'present': [24], 'situation': [25], 'ADR': [27, 38, 72, 76, 87, 112, 122, 136], 'monitoring.Methods:ADR': [28], 'reports': [29, 88], '2004~2006': [31], 'were': [32, 45, 55, 89, 105], 'downloaded': [33], 'from': [34], 'provincial': [35], 'center': [36], 'for': [37], 'monitoring': [39], 'interms': [40], 'Excel': [42], 'form.Some': [43], 'dataformats': [44], 'coverted': [46], 'or': [47], 'added': [48], 'necessarily.All': [49], 'items': [50], 'report': [53], 'form': [54], 'collected': [56], 'analyzed.Results:The': [58], 'anti-infective': [59], 'agents,': [60], 'antineoplastic': [61], 'agents': [62], 'TCM': [64], 'ranked': [65], 'first,': [66], 'second': [67], 'third': [69], 'among': [70], '1933': [71], 'reports.The': [73], 'lesions': [74], 'involved': [77, 106], 'body': [78], 'as': [79], 'a': [80, 147], 'whole-general': [81], 'disorders,': [82], 'then': [83], 'gastrointestinal': [84], 'system.1601': [85], '(82.8%)': [86], 'included': [90], 'by': [91], 'intravenous': [93], 'route': [94], 'administration.10': [96], 'categories': [97], 'drugs': [98], 'total': [100], '68': [101], 'kinds': [102], 'medicines': [104], '116': [108], 'new': [109, 133], 'severe': [111, 135], 'reports.Conclusion:The': [113], 'multiple': [114], 'factors': [115], 'lead': [116], 'to': [117, 130, 146], 'high': [119], 'frequency': [120], 'cases,': [123], 'especially': [124], 'use': [126], 'frequency.It': [127], 'is': [128], 'analyze': [131], 'reports,': [137], 'extract': [138], 'signal,': [139], 'expand': [140], 'safe': [141], 'research,': [142], 'announce': [143], 'pharmacovigilance,': [144], 'reduce': [145], 'lower': [148], 'rank': [149], 'use.': [152]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2353293259', 'counts_by_year': [], 'updated_date': '2024-12-08T14:17:02.825733', 'created_date': '2016-06-24'}